Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study

BACKGROUND: Secondary hyperparathyroidism (SHPT) is frequent in haemodialysis (HD) patients. Oral cinacalcet-hydrochloride (HCl) decreases parathyroid hormone (PTH); however, real-life PTH data, according to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, are still lacking. Our goal is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Kidney J
Main Authors: Rottembourg, Jacques, Ureña-Torres, Pablo, Toledano, Daniel, Gueutin, Victor, Hamani, Abdelaziz, Coldefy, Olivier, Hebibi, Hedia, Guincestre, Thomas, Emery, Corinne
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
CKD-Mbd
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885690/
https://ncbi.nlm.nih.gov/pubmed/31807302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfz021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados